I

L

IBBA , Luciano

Last name: IBBA

First name: Luciano

2023 (v1)

Publication

Metadata-only

Real-life effectiveness and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: A 104-week multicenter retrospective study - IL PSO (ITALIAN LANDSCAPE PSORIASIS)

Gargiulo, Luigi Ibba, Luciano Malagoli, Piergiorgio

BackgroundGuselkumab is a humanized monoclonal antibody that binds selectively to the p19 subunit of interleukin-23, which has shown efficacy in patients with previous incomplete response to ustekinumab in the NAVIGATE clinical trial. ObjectivesWe conducted a 104-week multicenter retrospective study to assess the effectiveness and safety of...

Uploaded on: February 14, 2024